Catalyst Calendar

Mon, Jul 6, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, Jun 25, 2026

1 updates

DFTX

4:15 PM

Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

definiumtx.com

Tue, Jun 23, 2026

1 updates

DFTX

9:57 PM

Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering

definiumtx.com

Mon, Jun 22, 2026

2 updates

DFTX

4:01 PM

Definium Therapeutics, Inc. Announces Proposed Public Offering

definiumtx.com

DFTX

7:00 AM

Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

Trial Results • Phase 3Topline results Mon, Jun 22, 2026, 7:00 AM EDTdefiniumtx.com

Sun, Jun 21, 2026

1 updates

DFTX

5:00 PM

Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026

Results Call • Phase 3Results call Mon, Jun 22, 2026, 8:00 AM EDTdefiniumtx.com

Mon, Jun 15, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Mon, Jun 1, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, May 21, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

definiumtx.com

Tue, May 12, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder

Trial Start • Phase 3Trial initiation Tue, May 12, 2026, 7:00 AM EDTdefiniumtx.com

Mon, May 11, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, May 7, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

Enrollment • Phase 3definiumtx.com

Thu, Apr 30, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

definiumtx.com

Wed, Apr 22, 2026

1 updates

DFTX

4:15 PM

Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

Enrollment • Phase 3definiumtx.com

Mon, Apr 20, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Sat, Apr 18, 2026

1 updates

DFTX

7:38 PM

Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments

definiumtx.com